Biomarin Pharmaceutical
BMRN
Reported
Tuesday, October 29
Q3 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | 0.52 | 0.91 | 0.39 | 75.00% |
| Revenue | 700M | 746M | 45.6M | 6.51% |
WhatIF - Earnings
EPS Beat Expectations by $0.39
Biomarin Pharmaceutical (BMRN:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything